- CARBONATE DERIVATIVE PRODUCTION METHOD
-
The objective of the present invention is to provide a method for producing a carbonate derivative in a safe and efficient manner. The method for producing a carbonate derivative according to the present invention is characterized in comprising irradiating light on a composition containing a C1-4 halogenated hydrocarbon having one or more kinds of halogen atoms selected from the group consisting of a chlorine atom, a bromine atom and an iodine atom, a nucleophilic functional group-containing compound and the specific base in the presence of oxygen.
- -
-
Paragraph 0174-0175
(2020/04/09)
-
- Preparation method of carbonyl diimidazole
-
The invention discloses a preparation method of carbonyl diimidazole in the technical field of carbonyl diimidazole synthesis. The preparation method comprises the steps of taking imidazole and hexamethyl disilazane as starting materials, obtaining N-trimethylsilyl imidazole through condensation, absorbing a single byproduct, namely ammonia through a sodium hydroxide solution, allowing N-trimethylsilyl imidazole to react with triphosgene to prepare carbonyl diimidazole, and filtering the principal product, namely carbonyl diimidazole, from liquid trimethylchlorosilane for vacuum drying. A removal step is simpler; the byproduct is gaseous and does not influence purity of the product, namely N-trimethylsilyl imidazole; a reactor with higher purity is provided for a subsequent reaction; in areaction process of N-trimethylsilyl imidazole and triphosgene, no catalyst is required to be added; the method is simple to operate; a byproduct of the reaction of N-trimethylsilyl imidazole and triphosgene is liquid trimethylchlorosilane; and carbonyl diimidazole prepared by the method is higher in purity and good in quality.
- -
-
Paragraph 0015; 0017; 0019; 0021; 0023; 0025; 0027-0032
(2019/02/03)
-
- Green synthesis of 1,1-Carbonyldiimidazole using copper oxide nanofiber as a heterogeneous catalyst
-
Poly(vinyl pyrrolidone) (PVP)/copper oxide composite nanofibers were prepared by electrospinning technique using PVP and copper acetate as precursors and calcinated at high temperature to yield polymer free, phase pure copper oxide nanofibers (CuO NFs). T
- Sukumar, Thenmozhi,Nallasamy, Dharmaraj
-
p. 234 - 241
(2017/12/12)
-
- Ionic liquids/ZnO nanoparticles as recyclable catalyst for polycarbonate depolymerization
-
A useful protocol for waste bis-phenol A-polycarbonates (BPA-PC) chemical recycling is proposed based on a bifunctional acid/basic catalyst composed by nanostructured zinc oxide and tetrabutylammonium chloride (ZnO-NPs/NBu4Cl) in quality of Lewis acid and base, respectively. Retro-polymerization reaction proved to be of general application for several nucleophiles, including water, alcohols, amines, polyols, aminols and polyamines, leading to the complete recovery of BPA monomer and enabling the PC polymer to function as a green carbonylating agent (green phosgene alternative) for preparing carbonates, urethanes and ureas. A complete depolymerization can be obtained in seven hours at 100 °C and ZnO nanocatalyst can be recycled several times without sensible loss of activity. Remarkably, when polycarbonate is reacted with glycerol, it is possible to realize in a single process the conversion of two industrial wastes (BPA-PC and glycerol) into two valuable chemicals like BPA monomer and glycerol carbonate (the latter being a useful industrial solvent and fuel additive).
- Iannone, Francesco,Casiello, Michele,Monopoli, Antonio,Cotugno, Pietro,Sportelli, Maria Chiara,Picca, Rosaria Anna,Cioffi, Nicola,Dell'Anna, Maria M.,Nacci, Angelo
-
p. 107 - 116
(2016/12/09)
-
- THE LITTLE MOLECULE COMPOUND WHICH USED FOR PROMOTING THE STEM CELLS HYPERPLASIA AND THE USE THEREOF
-
The invention provides small molecule compounds capable of accelerating proliferation of stem cells and uses thereof. The compounds play an important role in the research of stem cell proliferation mechanism. The invention further relates to the uses of the compounds and relevant compounds thereof in the preparation of stem cell proliferation accelerators and the preparation of medicines accelerating stem cell proliferation. The invention also relates to the uses of the compounds in the preparation of medicines for the treatment of various diseases arising from functional cells loss or damage. The diseases arising from stem cell trauma comprise diseases related to the degeneration or damage of nervous system cells, blood system diseases, diseases related to the loss or damage of cardiovascular cells, skin burn and the like.
- -
-
Page/Page column 9
(2012/03/12)
-
- Copolymerization of ethylene with 1-hexene promoted by novel multi-chelated non-metallocene complexes with imine bridged imidazole ligand
-
A series of novel bridged multi-chelated non-metallocene catalysts is synthesized by the treatment of N,N-imidazole, N,N-dimethylimidazole, and N,N-benzimidazole with n- BuLi, 2,6-dimethylaniline, and MCl4 (M = Ti, Zr) in THF. These catalysts are used for copolymerization of ethylene with 1-hexene after activated by methylaluminoxane (MAO). The effects of polymerization temperature, Al/M molar ratio, and pressure of monomer on ethylene copolymerization behaviors are investigated in detail. These results reveal that these catalysts are favorable for copolymerization of ethylene with 1-hexene featured high catalytic activity and high comonomer incorporation. The copolymer is characterized by 13C NMR, WAXD, GPC, and DSC. The results confirm that the obtained copolymer features broad molecular weight distribution (MWD) about 33-35 and high 1-hexene incorporation up to 9.2 mol %, melting temperature of the copolymer depends on the content of 1-hexene incorporation within the copolymer chain and 1-hexene unit in the copolymer chain isolates by ethylene units. The homopolymer of ethylene has broader MWD with 42-46.
- Ma, Lifu,Wang, Hongli,Yi, Jianjun,Huang, Qigu,Gao, Kejing,Yang, Wantai
-
experimental part
p. 417 - 424
(2010/11/04)
-
- IMPLANT COMPRISING A SURFACE OF REDUCED THROMBOGENICITY
-
An implant for a human or animal body, comprising a surface having reduced thrombogenic properties, whose surface has a wetting angle of Θ, where Θ≦80°. Also disclosed is a method for producing an implant and the use an implant to reduce the dose or concentration in administration of a concomitant systemic medication with one or more anticoagulant active ingredients before, during or after implantation of the implant in a human or animal body.
- -
-
-
- PROCESS FOR PRODUCING N,N'-CARBONYLDIIMIDAZOLE
-
The present invention provides a process for producing N,N'-carbonyldiimidazole, comprising: reacting phosgene, diphosgene, or triphosgene with imidazole in an inert solvent to produce N,N'-carbonyldiimidazole; to imidazole hydrochloride yielded as a by-product in the above step, adding a gaseous or liquid basic compound represented by the below-shown general formula (1) in an inert solvent to conduct neutralization reaction; and circulating the imidazole thus generated to use it as a starting material for N,N'-carbonyldiimidazole production. In the general formula (1), R 1 , R 2 , and R 3 each independently represents a hydrogen atom, a methyl group, or an ethyl group. The CDI produced by the production process of the invention is a compound useful in the fields of synthesis of pharmaceutical agents, synthesis of agricultural chemicals, peptide synthesis, and the like, e.g., intermolecular condensation reactions, intramolecular condensation reactions for synthesizing N-carboxylic anhydrides, production of activated esters, and the like. The compound is especially suitable for use in applications where colorlessness is required.
- -
-
Page/Page column 5
(2008/06/13)
-
- METHOD FOR THE PRODUCTION OF N,N -CARBONYLDIAZOLES
-
Disclosed is a method for producing N,N'-carbonyldiazoles by reacting azoles with phosgene in polar solvents from the group comprising ethers, ketones, and chlorinated aliphatic solvents. According to the inventive method, the azole and the phosgene are dosed such that 0.17 to 0.37 mole of phosgene are dosed during the time one mole of azole is dosed.
- -
-
Page/Page column 8-9
(2008/06/13)
-
- Process for the preparation of N,N'-Carbonyldiazoles
-
Preparation of N,N'-carbonyldiazole compounds (I) comprises reacting azole compounds (II) with phosgene, where a halogenated aliphatic solvent (chlorinated, brominated or mixed chlorinated/brominated aliphatic hydrocarbon) is used and total quantity of (II) is added, followed by the addition of phosgene. Preparation of N,N'-carbonyldiazole compounds of formula (I) comprises reacting azole compounds of formula (II) with phosgene, where a halogenated aliphatic solvent (chlorinated, brominated or mixed chlorinated/brominated aliphatic hydrocarbon) is used and total quantity of (II) is added, followed by the addition of phosgene. R 1>H or 1-6C alkyl; either R 2>H; and X 1>-X 3>CR 1>or N; or X 3>+R 2>forms -CH=CH-CH=CH- bridge; X 1>CR 1>; and (MK#5) X 2>= CR 1>or N. [Image].
- -
-
Page/Page column 6
(2008/06/13)
-
- Process for preparing N,N'-carbonyldiazoles
-
A process is provided for preparing N,N′-carbonyldiazoles by reacting azoles with phosgene in halogenated aliphatic hydrocarbon solvents, the entirety of the azole for reaction being introduced in the solvent, followed by the addition of phosgene.
- -
-
Page/Page column 4
(2008/06/13)
-
- New phenylalanine derivatives
-
Specified phenylalanine derivatives and analogues thereof have an antagonistic activity to α4 integrin. They are used as therapeutic agents for various diseases concerning α4 integrin.
- -
-
-
- Immobilizing mediator molecules via anchor molecules on metallic implant materials containing oxide layer
-
A mediator molecule is immobilized on the surface of a metallic or ceramic implant material. An anchor molecule such as a dialdehyde having a functional group that covalently binds the mediator molecule is covalently bound to the surface, and the mediator molecule is coupled to the functional group of the anchor molecule. The implant material may be composed of titanium, titanium alloy, aluminum, stainless steel or hydroxylapatite. Oxide units on the surface of the implant material can be increased preferably by treating with hot chromic-sulphuric acid for 0.5 to 3 hours at a temperature between 100 to 250° C. prior to binding the anchor molecule. Also, prior to binding the anchor molecule, the surface of the implant material can be activated by reacting with a silane derivative. Mediator molecules include BMP protein, ubiquitin and antibiotics, and the implant material may be an artificial joint or coronary vessel support such as a stent.
- -
-
-
- Method for producing carbonyl diimidazoles
-
In a process for preparing carbonyldiimidazole of the general formulae Ia, Ib, Ic or mixtures thereof where R1is hydrogen or a C1-4-alkyl radical and R2is hydrogen or a methyl radical, by reacting at least one imidazole of the general formulae IIa and IIb in which R1and R2have the abovementioned meaning, with phosgene in an inert solvent, stoichiometric amounts, based on the imidazoles, of an organic nitrogen base which has a lower pKbthan imidazole are added to the reaction mixture.
- -
-
Page column 4
(2010/02/05)
-
- Process for the production of N,N-carbonyl diimidazole
-
A high purity N,N-Carbonyl diimidazole (I) is obtained by the reaction of Imidazole, general formula-II, and bis (trichloromethyl) carbonate. Synthesis of N,N-Carbonyl diimidazole (I) is described:
- -
-
-
- Process for the preparation of N,N'-carbonyldiazoles and azolide salts
-
This invention relates to the preparation of N,N′-carbonyldiazoles in a particularly advantageous manner by reacting corresponding azolide salts with phosgene in an aromatic compound or an ether as solvent. The azolide salts are preferably prepared by a novel process from an azole that is reacted with a compound of the formula M′R7 or MgR8Z′ in the presence of a solvent.
- -
-
-
- Bicyclic amine derivatives
-
A compound represented by formula (I) or a salt thereof: STR1 wherein X1 and X2 each represent a halogen atom; R1 represents a hydrogen atom or a substituent; R2 represents a substituted or unsubstituted bicyclic heterocyclic substituent of the following formula; STR2 wherein R3, R4, Y, Z, m, n, p, q and r are as defined herein; A represents a nitrogen atom or a substituted carbon atom; and R represents a hydrogen atom or a substituent. The compound exhibits potent antimicrobial activity and also high safety due to reduced lipophilicity.
- -
-
-
- Pyridonecarboxylic acid derivatives
-
Quinolone derivatives are known as synthetic antimicrobial agents having a condensed pyridonecarboxylic acid skeleton, and those having substituents on various replaceable positions of said skeleton are known. In particular, if diastereomers exist, there are 4 or more kinds of stereoisomers. A mixture of diastereomers is a mixture of isomers having different physical properties and is difficult to apply as a drug as such. The present invention provides an antimicrobial 1-(1,2-cis-2-fluorocyclopropyl)-substituted quinolone derivative represented by formula I shown below which, although involving diastereomers, consists of a single stereoisomer. STR1 wherein R1 represents a methyl group, a difluoromethyl group, etc.; R2 represents a saturated nitrogen-containing heterocyclic group; A represents C--X3 or a nitrogen atom; X1 and X2 each represents a halogen atom; and X3 and Z represent a hydrogen atom, etc.
- -
-
-
- Saccharide intermediates in the formation of the calicheamicin and esperamicin oligosaccharides
-
Intermediates useful in preparing the calicheamicin and esperamicin oligosaccharides, and particularly the sulfur- and O-substituted hydroxylamine-containing B ring of both oligosaccharides, are disclosed as are methods of making and using the same, including the preparation of chimeric antibiotics using the same.
- -
-
-
- 3-SUBSTITUTED-2-OXINDOLE DERIVATIVES
-
This invention relates to novel 3-substituted-2-oxindole derivatives which are inhibitors of prostaglandin H 2 synthase, 5-lipoxygenase and interleukin-1 biosynthesis. The compounds of the invention are useful as inhibitors of prostaglandin H 2 synthase and interleukin-1 biosynthesis, per se, and as analgesic, antiinflammatory and antiarthritic agents in the treatment of chronic inflammatory diseases. This invention also relates to pharmaceutical compositions comprising said 3-substituted-2-oxindole derivatives; to methods of inhibiting prostaglandin H 2 synthase and biosynthesis of interleukin-1; and to treating chronic inflammatory diseases in a mammal with said compounds. Further, this invention relates to certain novel carboxylic acids useful as intermediates in the preparation of the 3-substituted-2-oxindole derivatives of this invention and to a process for the preparation of the 3-substituted-2-oxindole derivatives.
- -
-
-
- N-(arylthioalkyl)-N'-(aminoalkyl)ureas
-
N-(arylthioalkyl)-N'-(aminoalkyl)ureas and thioureas and oxidation derivatives having the formula STR1 wherein B is thio, sulfinyl or sulfonyl; R1 and R2 are hydrogen, loweralkyl, cycloalkyl, 2-furanyl, phenyl, substituted phenyl or phenyl-loweralkyl and R3 and R4 are hydrogen, loweralkyl, phenyl or phenyl-loweralkyl wherein phenyl is optionally substituted, or R3 and R4 taken with the adjacent nitrogen form a heterocyclic residue.
- -
-
-
